SCHEMBL18190858

SCHEMBL18190858

CCCC(=O)N(N)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27949340 0.83
SCHEMBL19782857 0.83 ALDH1A1 (0.48)
SCHEMBL27541545 0.81 CES2 (0.50)
SCHEMBL540699 0.78 FFAR3 (0.46)
SCHEMBL29110926 0.78 CES2 (0.45)
SCHEMBL10709726 0.77 CES2 (0.35)
SCHEMBL2245005 0.76
SCHEMBL20726028 0.76
SCHEMBL4088252 0.76
Stearic Acid SCHEMBL28175504 0.75 GPR84 (0.63)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3265448-A1 RILUZOLE PRODRUGS AND THEIR USE Biohaven Pharmaceutical Holding Company Ltd. (US) 2018-01-10 EP disclosed
WO-2016140879-A9 RILUZOLE PRODRUGS AND THEIR USE BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. (US) 2016-11-03 WO disclosed